Q1 2026
Ends Mar 31, 2026
Revenue
$1.6B
$1.6B to $1.6B
EPS
0.00
0.00 to 0.00
No analyst count
EPS: No analyst count
Apr 25, 10:50 PM UTC
stable/analyst-estimates
Healthcare
Live Price
Offline$76.03
+2.60% today
1Y Change
+6.47%
Window
Jun 25, 2025 → Jun 23, 2026
Coverage: 249 bars · Jun 25, 2025 → Jun 23, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Eurofins Scientific SE (ERFSF) is a Healthcare stock with a market cap of $10.61B and listed on OTC. The stock last traded around $76.03 and up 6.5% across the available one-year price window (Jun 25, 2025 → Jun 23, 2026). Baseline metrics include revenue growth of +4.9%, EPS growth of +23.9%, a dividend yield of 1.2%. What stands out right now is revenue +4.9%, EPS +23.9%, free cash flow -32.3% with operating margin 15.6% and ROIC 8.9%. The dividend is present but secondary, with a yield around 1.2%. Valuation is more restrained than many high-expectation growth names at P/E 23.0 and price/sales 1.5. Stock Foundry combines ERFSF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
ERFSF
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
ERFSF Max Drawdown
-22.71%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for ERFSF and SPY.
EPS Consensus
2.25
Range 0.00 -> 0.00
No analyst count
Revenue Outlook
$4.3B
Range $1.6B -> $1.6B
No analyst count
vs prior: +170.3%Price Target
--
-- -> --
No analyst count
Recommendations
--
No recommendation feed
No date
Consensus Spread
Lower spread suggests tighter agreement across covering analysts.
Next Earnings
EPS 2.25
Revenue $4.3B
No analyst count
EPS Revisions
No recent EPS revision rows
0 revision rows
Trend
Consensus average across visible periods
Trend
Average analyst revenue estimate
Timeline
Sorted by period end date. Includes both cached rows and live fallbacks from the configured analyst feed.
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.